|1320 Park Partners||-|
|Aetna Ventures||Connecticut, Hartford, United States|
|Boston MedTech Advisors||Dedham, Massachusetts, United States|
|Changzhou Properties||Changzhou, China, Zhejiang|
|Framework Ventures||Canada, Ontario, Toronto|
|Harel Hertz Investment House||Herzliya, Israel, Tel Aviv|
|Indaco Capital||Beijing, Beijing, China|
|Kashen Riye Touzi||China, Kashgar, Xinjiang|
|KJS Ahluwalia Group||India, Keonjhar, Odisha|
|Protocol Ventures||California, San Francisco, United States|
|Qantas Ventures||Australia, Mascot, New South Wales|
|Skyviews Life Science||-|
|Spectra Investments||Brazil, São Paulo, Sao Paulo|
|WuXi PharmaTech||China, Shanghai|
|Zappos||Las Vegas, Nevada, United States|
|Zhongjinqichen (Suzhou) Emerging Industry Equity Investment Fund||Changshu, China, Jiangxi|
|$23M||07 Jun 2021||London, England, United Kingdom|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.